$TLRY
Tilray Brands, Inc. Stock $tlry

$tlry Overview Financials Valuation SEC Filings Company Website

2024 Q3 Form 10-K Financial Statement

#000143774924023774 Filed on July 30, 2024

Income Statement

Concept	2024 Q3	2024 Q2	2024
Revenue	$200.0M	$229.9M	$788.9M
YoY Change	13.05%	24.81%	25.8%
Cost Of Revenue	$140.3M	$147.5M	$565.6M
YoY Change	5.71%	26.07%	17.79%
Gross Profit	$59.71M	$82.35M	$223.4M
YoY Change	35.09%	22.61%	51.98%
Gross Profit Margin	29.85%	35.82%	28.31%
Selling, General & Admin	$55.80M	$73.59M	$204.6M
YoY Change	17.79%	-163.04%	-11.43%
% of Gross Profit	93.46%	89.36%	91.6%
Research & Development	$105.0K	$394.0K	$635.0K
YoY Change	32.91%	118.89%	-6.89%
% of Gross Profit	0.18%	0.48%	0.28%
Depreciation & Amortization	$31.81M	$31.73M	$126.9M
YoY Change	3.33%	9.44%	-2.49%
% of Gross Profit	53.28%	38.53%	56.82%
Operating Expenses	$96.28M	$94.03M	$398.1M
YoY Change	22.55%	-199.35%	22.11%
Operating Profit	-$36.57M	-$11.68M	-$174.7M
YoY Change	6.43%	-107.22%	-2.4%
Interest Expense	-$9.842M	-$23.54M	$49.26M
YoY Change	0.07%	-91.2%	-115.45%
% of Operating Profit
Other Income/Expense, Net	$12.65M	-$2.940M	-$37.84M
YoY Change	-387.28%	590.14%	374.75%
Pretax Income	-$33.77M	-$43.00M	-$249.0M
YoY Change	-30.52%	-61.5%	-82.83%
Income Tax	$886.0K	-$27.63M	-$26.62M
% Of Pretax Income
Net Earnings	-$39.17M	-$31.75M	-$245.0M
YoY Change	-45.24%	-77.11%	-83.14%
Net Earnings / Revenue	-19.58%	-13.81%	-31.05%
Basic Earnings Per Share	-$0.04		-$0.33
Diluted Earnings Per Share	-$0.04	-$0.04	-$0.33
COMMON SHARES
Basic Shares Outstanding	843.0M	774.0M	742.6M
Diluted Shares Outstanding	875.4M		742.6M

Balance Sheet

Concept	2024 Q3	2024 Q2	2024
SHORT-TERM ASSETS
Cash & Short-Term Investments	$280.1M	$260.5M	$260.5M
YoY Change	-39.76%	-41.92%	-41.92%
Cash & Equivalents	$205.2M	$228.3M	$228.3M
Short-Term Investments	$74.87M	$32.18M	$32.18M
Other Short-Term Assets	$77.50M	$63.41M	$63.41M
YoY Change	54.37%	68.09%	68.09%
Inventory	$264.3M	$252.1M	$252.1M
Prepaid Expenses
Receivables	$104.0M	$101.7M	$101.7M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$725.9M	$677.7M	$677.7M
YoY Change	-12.47%	-12.33%	-12.33%
LONG-TERM ASSETS
Property, Plant & Equipment	$555.1M	$558.2M	$574.3M
YoY Change	12.24%	28.15%	31.85%
Goodwill	$2.010B	$2.009B
YoY Change	0.0%	0.0%
Intangibles	$908.8M	$915.5M
YoY Change	-6.08%	-5.99%
Long-Term Investments	$7.853M	$0.00	$7.859M
YoY Change	69.32%	-100.0%	-36.47%
Other Assets	$5.337M	$5.395M	$5.395M
YoY Change	-38.28%	2330.18%	2330.18%
Total Long-Term Assets	$3.536B	$3.544B	$3.544B
YoY Change	-1.04%	0.28%	0.28%
TOTAL ASSETS
Total Short-Term Assets	$725.9M	$677.7M	$677.7M
Total Long-Term Assets	$3.536B	$3.544B	$3.544B
Total Assets	$4.262B	$4.222B	$4.222B
YoY Change	-3.19%	-1.99%	-1.99%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$101.9M	$105.4M	$105.4M
YoY Change	28.99%	48.82%	48.82%
Accrued Expenses	$90.90M	$92.42M	$131.2M
YoY Change	-29.82%	-13.91%	22.19%
Deferred Revenue
YoY Change
Short-Term Debt	$18.13M	$18.03M	$18.03M
YoY Change	24.26%	-22.87%	-22.87%
Long-Term Debt Due	$17.19M	$16.93M	$16.93M
YoY Change	-93.52%	-91.47%	-91.47%
Total Short-Term Liabilities	$293.5M	$299.2M	$299.2M
YoY Change	-45.36%	-30.9%	-30.9%
LONG-TERM LIABILITIES
Long-Term Debt	$331.7M	$331.9M	$331.9M
YoY Change	21.35%	-10.02%	-10.02%
Other Long-Term Liabilities	$99.00K	$90.00K	$16.56M
YoY Change	33.78%	-98.9%	103.21%
Total Long-Term Liabilities	$99.00K	$90.00K	$348.4M
YoY Change	33.78%	-99.98%	-7.57%
TOTAL LIABILITIES
Total Short-Term Liabilities	$293.5M	$299.2M	$299.2M
Total Long-Term Liabilities	$99.00K	$90.00K	$348.4M
Total Liabilities	$778.5M	$778.5M	$778.8M
YoY Change	-22.21%	-21.49%	-21.46%
SHAREHOLDERS EQUITY
Retained Earnings	-$2.700B	-$2.660B
YoY Change	8.55%	10.14%
Common Stock	$6.218B	$6.147B
YoY Change	5.21%	6.39%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$3.478B	$3.443B	$3.443B
YoY Change
Total Liabilities & Shareholders Equity	$4.262B	$4.222B	$4.222B
YoY Change	-3.19%	-1.99%	-1.99%

Cashflow Statement

Concept	2024 Q3	2024 Q2	2024
OPERATING ACTIVITIES
Net Income	-$39.17M	-$31.75M	-$245.0M
YoY Change	-45.24%	-77.11%	-83.14%
Depreciation, Depletion And Amortization	$31.81M	$31.73M	$126.9M
YoY Change	3.33%	9.44%	-2.49%
Cash From Operating Activities	-$35.31M	$30.71M	-$30.91M
YoY Change	122.87%	-29.57%	-490.91%
INVESTING ACTIVITIES
Capital Expenditures	$6.736M	$9.710M	$29.25M
YoY Change	62.31%	-21.73%	40.62%
Acquisitions	$0.00		$60.63M
YoY Change	-100.0%		126.91%
Other Investing Activities	-$42.66M	$54.77M	$157.6M
YoY Change	92.68%	1035.75%	-159.63%
Cash From Investing Activities	-$49.40M	$45.06M	$128.3M
YoY Change	87.89%	-694.09%	-145.02%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net			$8.619M
YoY Change			-93.29%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	$60.59M	7.070M	-$75.19M
YoY Change	332.23%	13.37%	-207.17%
NET CHANGE
Cash From Operating Activities	-$35.31M	30.71M	-$30.91M
Cash From Investing Activities	-$49.40M	45.06M	$128.3M
Cash From Financing Activities	$60.59M	7.070M	-$75.19M
Net Change In Cash	-$23.15M	82.83M	$21.71M
YoY Change	-15.8%	96.05%	-110.48%
FREE CASH FLOW
Cash From Operating Activities	-$35.31M	$30.71M	-$30.91M
Capital Expenditures	$6.736M	$9.710M	$29.25M
Free Cash Flow	-$42.04M	$21.00M	-$60.15M
YoY Change	110.3%	-32.68%	366.53%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2024	dei	Amendment Flag AmendmentFlag	false
CY2024	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--05-31
CY2024	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2024	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2024
CY2024Q2	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2023Q2	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2024Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2023Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2024Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	1198000000
CY2023Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	980000000
CY2024Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	831925373
CY2024Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	831925373
CY2023Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	656655455
CY2023Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	656655455
CY2024Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2023Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2024Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000
CY2023Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000
CY2024Q2	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0
CY2024Q2	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0
CY2023Q2	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0
CY2023Q2	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0
CY2024	tlry	Cash And Cash Equivalents Maturity Period CashAndCashEquivalentsMaturityPeriod	P3M
CY2024Q2	us-gaap	Restricted Cash Current RestrictedCashCurrent	0	usd
CY2023Q2	us-gaap	Restricted Cash Current RestrictedCashCurrent	0	usd
CY2024	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	4	pure
CY2023	us-gaap	Impairment Long Lived Asset Held For Use Statement Of Income Or Comprehensive Income Extensible Enumeration ImpairmentLongLivedAssetHeldForUseStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration	http://fasb.org/us-gaap/2024#AssetImpairmentCharges
CY2024Q2	us-gaap	Finance Lease Liability Current Statement Of Financial Position Extensible List FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList	http://www.tilray.com/20240531#OperatingAndFinanceLeaseLiabilityCurrent
CY2023Q2	us-gaap	Finance Lease Liability Current Statement Of Financial Position Extensible List FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList	http://www.tilray.com/20240531#OperatingAndFinanceLeaseLiabilityCurrent
CY2024Q2	us-gaap	Operating Lease Liability Current Statement Of Financial Position Extensible List OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList	http://www.tilray.com/20240531#OperatingAndFinanceLeaseLiabilityCurrent
CY2023Q2	us-gaap	Operating Lease Liability Current Statement Of Financial Position Extensible List OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList	http://www.tilray.com/20240531#OperatingAndFinanceLeaseLiabilityCurrent
CY2024Q2	us-gaap	Finance Lease Liability Noncurrent Statement Of Financial Position Extensible List FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList	http://www.tilray.com/20240531#OperatingAndFinanceLeaseLiabilityNoncurrent
CY2023Q2	us-gaap	Finance Lease Liability Noncurrent Statement Of Financial Position Extensible List FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList	http://www.tilray.com/20240531#OperatingAndFinanceLeaseLiabilityNoncurrent
CY2024Q2	us-gaap	Operating Lease Liability Noncurrent Statement Of Financial Position Extensible List OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList	http://www.tilray.com/20240531#OperatingAndFinanceLeaseLiabilityNoncurrent
CY2023Q2	us-gaap	Operating Lease Liability Noncurrent Statement Of Financial Position Extensible List OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList	http://www.tilray.com/20240531#OperatingAndFinanceLeaseLiabilityNoncurrent
CY2022	us-gaap	Impairment Intangible Asset Statement Of Income Or Comprehensive Income Extensible Enumeration ImpairmentIntangibleAssetStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration	http://fasb.org/us-gaap/2024#AssetImpairmentCharges
CY2024	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	usd
CY2024	us-gaap	Proceeds From Sale Of Equity Method Investments ProceedsFromSaleOfEquityMethodInvestments	0	usd
CY2023	us-gaap	Proceeds From Sale Of Equity Method Investments ProceedsFromSaleOfEquityMethodInvestments	0	usd
CY2022	us-gaap	Proceeds From Sale Of Equity Method Investments ProceedsFromSaleOfEquityMethodInvestments	0	usd
CY2024Q2	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	0	usd
CY2023Q2	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	0	usd
CY2022Q2	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	0	usd
CY2024	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Expense UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense	0	usd
CY2023	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Expense UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense	0	usd
CY2022	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Expense UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense	0	usd
CY2024Q2	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued	0	usd
CY2023Q2	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued	0	usd
CY2024Q2	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	6209000
CY2023Q2	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	6209000
CY2023Q2	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	5.95
CY2024Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	831925373
CY2024Q2	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0
CY2024Q2	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0
CY2023Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	656655455
CY2023Q2	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0
CY2023Q2	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0
CY2023Q2	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	6641000	usd
CY2024	us-gaap	Allowance For Doubtful Accounts Receivable Period Increase Decrease AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease	1073000	usd
CY2024Q2	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	7714000	usd
CY2024	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	4	pure
CY2024	ecd	Rule10b51 Arr Adopted Flag Rule10b51ArrAdoptedFlag	false
CY2024	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false
CY2024	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false
CY2024	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
CY2024	dei	Document Type DocumentType	10-K
CY2024	dei	Document Annual Report DocumentAnnualReport	true
CY2024	dei	Document Period End Date DocumentPeriodEndDate	2024-05-31
CY2024	dei	Document Transition Report DocumentTransitionReport	false
CY2024	dei	Entity File Number EntityFileNumber	001-38594
CY2024	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2024	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	82-4310622
CY2024	dei	Entity Address Address Line1 EntityAddressAddressLine1	265 Talbot Street West
CY2024	dei	Entity Address City Or Town EntityAddressCityOrTown	Leamington
CY2024	dei	Entity Address State Or Province EntityAddressStateOrProvince	ON
CY2024	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	N8H 5L4
CY2024	dei	City Area Code CityAreaCode	844
CY2024	dei	Local Phone Number LocalPhoneNumber	845-7291
CY2024	dei	Security12b Title Security12bTitle	Common Stock, $0.0001 par value per share
CY2024	dei	Trading Symbol TradingSymbol	TLRY
CY2024	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2024	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	Yes
CY2024	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2024	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2024	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2024	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
CY2024	dei	Entity Small Business EntitySmallBusiness	false
CY2024	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2024	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	true
CY2024	dei	Document Fin Stmt Error Correction Flag DocumentFinStmtErrorCorrectionFlag	false
CY2024	dei	Entity Shell Company EntityShellCompany	false
CY2023Q4	dei	Entity Public Float EntityPublicFloat	1300000000	usd
CY2024Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	842961757
CY2024Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	228340000	usd
CY2023Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	206632000	usd
CY2024Q2	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	32182000	usd
CY2023Q2	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	241897000	usd
CY2024Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	101695000	usd
CY2023Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	86227000	usd
CY2024Q2	us-gaap	Inventory Net InventoryNet	252087000	usd
CY2023Q2	us-gaap	Inventory Net InventoryNet	200551000	usd
CY2024Q2	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	31332000	usd
CY2023Q2	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	37722000	usd
CY2024Q2	us-gaap	Assets Held For Sale Not Part Of Disposal Group Current AssetsHeldForSaleNotPartOfDisposalGroupCurrent	32074000	usd
CY2023Q2	us-gaap	Assets Held For Sale Not Part Of Disposal Group Current AssetsHeldForSaleNotPartOfDisposalGroupCurrent	0	usd
CY2024Q2	us-gaap	Assets Current AssetsCurrent	677710000	usd
CY2023Q2	us-gaap	Assets Current AssetsCurrent	773029000	usd
CY2024Q2	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization	558247000	usd
CY2023Q2	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization	429667000	usd
CY2024Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	16101000	usd
CY2023Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	5941000	usd
CY2024Q2	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	915469000	usd
CY2023Q2	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	973785000	usd
CY2024Q2	us-gaap	Goodwill Goodwill	2008884000	usd
CY2023Q2	us-gaap	Goodwill Goodwill	2008843000	usd
CY2024Q2	us-gaap	Equity Method Investments EquityMethodInvestments	0	usd
CY2023Q2	us-gaap	Equity Method Investments EquityMethodInvestments	4576000	usd
CY2024Q2	us-gaap	Other Long Term Investments OtherLongTermInvestments	7859000	usd
CY2023Q2	us-gaap	Other Long Term Investments OtherLongTermInvestments	7795000	usd
CY2024Q2	us-gaap	Notes And Loans Receivable Net Noncurrent NotesAndLoansReceivableNetNoncurrent	32000000	usd
CY2023Q2	us-gaap	Notes And Loans Receivable Net Noncurrent NotesAndLoansReceivableNetNoncurrent	103401000	usd
CY2024Q2	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	5395000	usd
CY2023Q2	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	222000	usd
CY2024Q2	us-gaap	Assets Assets	4221665000	usd
CY2023Q2	us-gaap	Assets Assets	4307259000	usd
CY2024Q2	us-gaap	Short Term Borrowings ShortTermBorrowings	18033000	usd
CY2023Q2	us-gaap	Short Term Borrowings ShortTermBorrowings	23381000	usd
CY2024Q2	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	241957000	usd
CY2023Q2	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	190682000	usd
CY2024Q2	us-gaap	Business Combination Contingent Consideration Liability Current BusinessCombinationContingentConsiderationLiabilityCurrent	15000000	usd
CY2023Q2	us-gaap	Business Combination Contingent Consideration Liability Current BusinessCombinationContingentConsiderationLiabilityCurrent	16218000	usd
CY2024Q2	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	3253000	usd
CY2023Q2	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	1817000	usd
CY2024Q2	tlry	Operating And Finance Lease Liability Current OperatingAndFinanceLeaseLiabilityCurrent	5091000	usd
CY2023Q2	tlry	Operating And Finance Lease Liability Current OperatingAndFinanceLeaseLiabilityCurrent	2423000	usd
CY2024Q2	us-gaap	Secured Debt Current SecuredDebtCurrent	15506000	usd
CY2023Q2	us-gaap	Secured Debt Current SecuredDebtCurrent	24080000	usd
CY2024Q2	us-gaap	Convertible Debt Current ConvertibleDebtCurrent	330000	usd
CY2023Q2	us-gaap	Convertible Debt Current ConvertibleDebtCurrent	174378000	usd
CY2024Q2	us-gaap	Liabilities Current LiabilitiesCurrent	299170000	usd
CY2023Q2	us-gaap	Liabilities Current LiabilitiesCurrent	432979000	usd
CY2024Q2	us-gaap	Business Combination Contingent Consideration Liability Noncurrent BusinessCombinationContingentConsiderationLiabilityNoncurrent	0	usd
CY2023Q2	us-gaap	Business Combination Contingent Consideration Liability Noncurrent BusinessCombinationContingentConsiderationLiabilityNoncurrent	10889000	usd
CY2024Q2	tlry	Operating And Finance Lease Liability Noncurrent OperatingAndFinanceLeaseLiabilityNoncurrent	60422000	usd
CY2023Q2	tlry	Operating And Finance Lease Liability Noncurrent OperatingAndFinanceLeaseLiabilityNoncurrent	7936000	usd
CY2024Q2	us-gaap	Secured Long Term Debt SecuredLongTermDebt	158352000	usd
CY2023Q2	us-gaap	Secured Long Term Debt SecuredLongTermDebt	136889000	usd
CY2024Q2	us-gaap	Convertible Debt Noncurrent ConvertibleDebtNoncurrent	129583000	usd
CY2023Q2	us-gaap	Convertible Debt Noncurrent ConvertibleDebtNoncurrent	221044000	usd
CY2024Q2	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	130870000	usd
CY2023Q2	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	167364000	usd
CY2024Q2	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	90000	usd
CY2023Q2	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	215000	usd
CY2024Q2	us-gaap	Liabilities Liabilities	778487000	usd
CY2023Q2	us-gaap	Liabilities Liabilities	977316000	usd
CY2024Q2	us-gaap	Common Stock Value CommonStockValue	83000	usd
CY2023Q2	us-gaap	Common Stock Value CommonStockValue	66000	usd
CY2024Q2	us-gaap	Preferred Stock Value PreferredStockValue	0	usd
CY2023Q2	us-gaap	Preferred Stock Value PreferredStockValue	0	usd
CY2024Q2	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	6146810000	usd
CY2023Q2	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	5777743000	usd
CY2024Q2	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-43499000	usd
CY2023Q2	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-46610000	usd
CY2024Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-2660488000	usd
CY2023Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-2415507000	usd
CY2024Q2	us-gaap	Stockholders Equity StockholdersEquity	3442906000	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	3315692000	usd
CY2024Q2	us-gaap	Minority Interest MinorityInterest	272000	usd
CY2023Q2	us-gaap	Minority Interest MinorityInterest	14251000	usd
CY2024Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	3443178000	usd
CY2023Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	3329943000	usd
CY2024Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	4221665000	usd
CY2023Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	4307259000	usd
CY2024	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	788942000	usd
CY2023	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	627124000	usd
CY2022	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	628372000	usd
CY2024	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	565591000	usd
CY2023	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	480164000	usd
CY2022	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	511555000	usd
CY2024	us-gaap	Gross Profit GrossProfit	223351000	usd
CY2023	us-gaap	Gross Profit GrossProfit	146960000	usd
CY2022	us-gaap	Gross Profit GrossProfit	116817000	usd
CY2024	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	167358000	usd
CY2023	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	165159000	usd
CY2022	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	162801000	usd
CY2024	us-gaap	Selling Expense SellingExpense	37233000	usd
CY2023	us-gaap	Selling Expense SellingExpense	34840000	usd
CY2022	us-gaap	Selling Expense SellingExpense	34926000	usd
CY2024	us-gaap	Amortization Of Deferred Charges AmortizationOfDeferredCharges	84752000	usd
CY2023	us-gaap	Amortization Of Deferred Charges AmortizationOfDeferredCharges	93489000	usd
CY2022	us-gaap	Amortization Of Deferred Charges AmortizationOfDeferredCharges	115191000	usd
CY2024	us-gaap	Marketing And Advertising Expense MarketingAndAdvertisingExpense	41933000	usd
CY2023	us-gaap	Marketing And Advertising Expense MarketingAndAdvertisingExpense	30937000	usd
CY2022	us-gaap	Marketing And Advertising Expense MarketingAndAdvertisingExpense	30934000	usd
CY2024	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	635000	usd
CY2023	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	682000	usd
CY2022	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1518000	usd
CY2024	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	-15790000	usd
CY2023	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	855000	usd
CY2022	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	-44650000	usd
CY2024	us-gaap	Asset Impairment Charges AssetImpairmentCharges	0	usd
CY2023	us-gaap	Asset Impairment Charges AssetImpairmentCharges	934000000	usd
CY2022	us-gaap	Asset Impairment Charges AssetImpairmentCharges	378241000	usd
CY2024	tlry	Otherthantemporary Fair Value Loss Convertible Notes Receivable OtherthantemporaryFairValueLossConvertibleNotesReceivable	42681000	usd
CY2023	tlry	Otherthantemporary Fair Value Loss Convertible Notes Receivable OtherthantemporaryFairValueLossConvertibleNotesReceivable	246330000	usd
CY2022	tlry	Otherthantemporary Fair Value Loss Convertible Notes Receivable OtherthantemporaryFairValueLossConvertibleNotesReceivable	0	usd
CY2024	us-gaap	Litigation Settlement Expense LitigationSettlementExpense	8251000	usd
CY2023	us-gaap	Litigation Settlement Expense LitigationSettlementExpense	-505000	usd
CY2022	us-gaap	Litigation Settlement Expense LitigationSettlementExpense	16518000	usd
CY2024	us-gaap	Restructuring Charges RestructuringCharges	15581000	usd
CY2023	us-gaap	Restructuring Charges RestructuringCharges	9245000	usd
CY2022	us-gaap	Restructuring Charges RestructuringCharges	795000	usd
CY2024	tlry	Transaction Costs Income TransactionCostsIncome	15462000	usd
CY2023	tlry	Transaction Costs Income TransactionCostsIncome	1613000	usd
CY2022	tlry	Transaction Costs Income TransactionCostsIncome	30944000	usd
CY2024	us-gaap	Operating Expenses OperatingExpenses	398096000	usd
CY2023	us-gaap	Operating Expenses OperatingExpenses	1516645000	usd
CY2022	us-gaap	Operating Expenses OperatingExpenses	727218000	usd
CY2024	us-gaap	Operating Income Loss OperatingIncomeLoss	-174745000	usd
CY2023	us-gaap	Operating Income Loss OperatingIncomeLoss	-1369685000	usd
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	-610401000	usd
CY2024	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	-36433000	usd
CY2023	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	-13587000	usd
CY2022	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	-27944000	usd
CY2024	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-37842000	usd
CY2023	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-66909000	usd
CY2022	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	197671000	usd
CY2024	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-249020000	usd
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-1450181000	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-440674000	usd
CY2024	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-26616000	usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-7181000	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-6542000	usd
CY2024	us-gaap	Profit Loss ProfitLoss	-222404000	usd
CY2023	us-gaap	Profit Loss ProfitLoss	-1443000000	usd
CY2022	us-gaap	Profit Loss ProfitLoss	-434132000	usd
CY2024	us-gaap	Net Income Loss NetIncomeLoss	-244981000	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-1452656000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-476801000	usd
CY2024	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	22577000	usd
CY2023	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	9656000	usd
CY2022	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	42669000	usd
CY2024	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	3121000	usd
CY2023	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-83533000	usd
CY2022	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-125306000	usd
CY2024	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	0	usd
CY2023	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	75177000	usd
CY2022	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	-71428000	usd
CY2024	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	3121000	usd
CY2023	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-8356000	usd
CY2022	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-196734000	usd
CY2024	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-219283000	usd
CY2023	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-1451356000	usd
CY2022	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-630866000	usd
CY2024	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-241870000	usd
CY2023	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-1478502000	usd
CY2022	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-650233000	usd
CY2024	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	22587000	usd
CY2023	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	27146000	usd
CY2022	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	19367000	usd
CY2024	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	742649477
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	617982589
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	481219130
CY2024	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	742649477
CY2023	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	617982589
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	481219130
CY2024	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.33
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-2.35
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.99
CY2024	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.33
CY2023	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-2.35
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.99
CY2021Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	4465313000	usd
CY2022	us-gaap	Noncontrolling Interest Increase From Subsidiary Equity Issuance NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance	52995000	usd
CY2022	tlry	Stock Issued During Period Value Equity Financing StockIssuedDuringPeriodValueEquityFinancing	262509000	usd
CY2022	tlry	Stock Issued During Period Value Settlement Of Financing Liability StockIssuedDuringPeriodValueSettlementOfFinancingLiability	-7484000	usd
CY2022	tlry	Stock Issued During Period Value Legal Settlement StockIssuedDuringPeriodValueLegalSettlement	22170000	usd
CY2022	tlry	Stock Issued During Period Value Purchase Of Capital And Intangible Assets StockIssuedDuringPeriodValuePurchaseOfCapitalAndIntangibleAssets	12146000	usd
CY2022	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	5403000	usd
CY2022	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures	0	usd
CY2022	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	8686000	usd
CY2022	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	35994000	usd
CY2022	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-630866000	usd
CY2022Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	4441366000	usd
CY2023	tlry	Stock Issued During Period Value Equity Financing StockIssuedDuringPeriodValueEquityFinancing	129593000	usd
CY2023	us-gaap	Stock Issued During Period Value Purchase Of Assets StockIssuedDuringPeriodValuePurchaseOfAssets	107272000	usd
CY2023	tlry	Stock Issued During Period Value Settlement Of Financing Liability StockIssuedDuringPeriodValueSettlementOfFinancingLiability	12467000	usd
CY2023	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	0	usd
CY2023	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures	0	usd
CY2023	tlry	Stock Issued During Period Value Convertible Notes Share Lending Agreement StockIssuedDuringPeriodValueConvertibleNotesShareLendingAgreement	26161000	usd
CY2023	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	1189000	usd
CY2023	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	39595000	usd
CY2023	us-gaap	Minority Interest Decrease From Distributions To Noncontrolling Interest Holders MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders	7858000	usd
CY2023	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-1451356000	usd
CY2023Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	3329943000	usd
CY2024	tlry	Stock Issued During Period Value Settlement Of Acquisition Liabilities StockIssuedDuringPeriodValueSettlementOfAcquisitionLiabilities	1500000	usd
CY2024	tlry	Stock Issued During Period Value Settlement Of Financing Liability StockIssuedDuringPeriodValueSettlementOfFinancingLiability	21487000	usd
CY2024	tlry	Stock Issued During Period Value Settlement Of Convertible Securities StockIssuedDuringPeriodValueSettlementOfConvertibleSecurities	52313000	usd
CY2024	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	4860000	usd
CY2024	us-gaap	Adjustments To Additional Paid In Capital Equity Component Of Convertible Debt AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt	3953000	usd
CY2024	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	8619000	usd
CY2024	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	0	usd
CY2024	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures	0	usd
CY2024	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	31769000	usd
CY2024	us-gaap	Minority Interest Decrease From Distributions To Noncontrolling Interest Holders MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders	10349000	usd
CY2024	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-219283000	usd
CY2024Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	3443178000	usd
CY2024	us-gaap	Profit Loss ProfitLoss	-222404000	usd
CY2023	us-gaap	Profit Loss ProfitLoss	-1443000000	usd
CY2022	us-gaap	Profit Loss ProfitLoss	-434132000	usd
CY2024	us-gaap	Deferred Income Taxes And Tax Credits DeferredIncomeTaxesAndTaxCredits	-38872000	usd
CY2023	us-gaap	Deferred Income Taxes And Tax Credits DeferredIncomeTaxesAndTaxCredits	-31953000	usd
CY2022	us-gaap	Deferred Income Taxes And Tax Credits DeferredIncomeTaxesAndTaxCredits	-27538000	usd
CY2024	us-gaap	Foreign Currency Transaction Gain Loss Unrealized ForeignCurrencyTransactionGainLossUnrealized	-3756000	usd
CY2023	us-gaap	Foreign Currency Transaction Gain Loss Unrealized ForeignCurrencyTransactionGainLossUnrealized	-17768000	usd
CY2022	us-gaap	Foreign Currency Transaction Gain Loss Unrealized ForeignCurrencyTransactionGainLossUnrealized	-18001000	usd
CY2024	us-gaap	Adjustment For Amortization AdjustmentForAmortization	126913000	usd
CY2023	us-gaap	Adjustment For Amortization AdjustmentForAmortization	130149000	usd
CY2022	us-gaap	Adjustment For Amortization AdjustmentForAmortization	154592000	usd
CY2024	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	4198000	usd
CY2023	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	48000	usd
CY2022	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	682000	usd
CY2024	us-gaap	Accretion Expense AccretionExpense	14459000	usd
CY2023	us-gaap	Accretion Expense AccretionExpense	3848000	usd
CY2022	us-gaap	Accretion Expense AccretionExpense	5042000	usd
CY2024	us-gaap	Inventory Write Down InventoryWriteDown	0	usd
CY2023	us-gaap	Inventory Write Down InventoryWriteDown	55000000	usd
CY2022	us-gaap	Inventory Write Down InventoryWriteDown	67000000	usd
CY2024	us-gaap	Asset Impairment Charges AssetImpairmentCharges	0	usd
CY2023	us-gaap	Asset Impairment Charges AssetImpairmentCharges	934001000	usd
CY2022	us-gaap	Asset Impairment Charges AssetImpairmentCharges	378240000	usd
CY2024	tlry	Otherthantemporary Fair Value Loss Convertible Notes Receivable OtherthantemporaryFairValueLossConvertibleNotesReceivable	42681000	usd
CY2023	tlry	Otherthantemporary Fair Value Loss Convertible Notes Receivable OtherthantemporaryFairValueLossConvertibleNotesReceivable	246330000	usd
CY2022	tlry	Otherthantemporary Fair Value Loss Convertible Notes Receivable OtherthantemporaryFairValueLossConvertibleNotesReceivable	0	usd
CY2024	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-13626000	usd
CY2023	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-11406000	usd
CY2022	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	9647000	usd
CY2024	us-gaap	Share Based Compensation ShareBasedCompensation	31769000	usd
CY2023	us-gaap	Share Based Compensation ShareBasedCompensation	39595000	usd
CY2022	us-gaap	Share Based Compensation ShareBasedCompensation	35994000	usd
CY2024	us-gaap	Gain Loss On Sale Of Investments GainLossOnSaleOfInvestments	-4855000	usd
CY2023	us-gaap	Gain Loss On Sale Of Investments GainLossOnSaleOfInvestments	-2190000	usd
CY2022	us-gaap	Gain Loss On Sale Of Investments GainLossOnSaleOfInvestments	-4914000	usd
CY2024	us-gaap	Gain Loss On Derivative Instruments Net Pretax GainLossOnDerivativeInstrumentsNetPretax	-21172000	usd
CY2023	us-gaap	Gain Loss On Derivative Instruments Net Pretax GainLossOnDerivativeInstrumentsNetPretax	-27365000	usd
CY2022	us-gaap	Gain Loss On Derivative Instruments Net Pretax GainLossOnDerivativeInstrumentsNetPretax	232625000	usd
CY2024	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	-15790000	usd
CY2023	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	855000	usd
CY2022	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	-44650000	usd
CY2024	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	6575000	usd
CY2023	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-4168000	usd
CY2022	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	5842000	usd
CY2024	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-13069000	usd
CY2023	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-3122000	usd
CY2022	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-4472000	usd
CY2024	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	15578000	usd
CY2023	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	12934000	usd
CY2022	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	45749000	usd
CY2024	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	212000	usd
CY2023	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	20044000	usd
CY2022	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-44652000	usd
CY2024	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-30905000	usd
CY2023	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	7906000	usd
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-177262000	usd
CY2024	us-gaap	Payments To Acquire Productive Assets PaymentsToAcquireProductiveAssets	29249000	usd
CY2023	us-gaap	Payments To Acquire Productive Assets PaymentsToAcquireProductiveAssets	20800000	usd
CY2022	us-gaap	Payments To Acquire Productive Assets PaymentsToAcquireProductiveAssets	34064000	usd
CY2024	us-gaap	Proceeds From Sale Of Productive Assets ProceedsFromSaleOfProductiveAssets	8509000	usd
CY2023	us-gaap	Proceeds From Sale Of Productive Assets ProceedsFromSaleOfProductiveAssets	4304000	usd
CY2022	us-gaap	Proceeds From Sale Of Productive Assets ProceedsFromSaleOfProductiveAssets	12205000	usd
CY2024	tlry	Payments Proceeds To Acquire Marketable Securities PaymentsProceedsToAcquireMarketableSecurities	-209715000	usd
CY2023	tlry	Payments Proceeds To Acquire Marketable Securities PaymentsProceedsToAcquireMarketableSecurities	241897000	usd
CY2022	tlry	Payments Proceeds To Acquire Marketable Securities PaymentsProceedsToAcquireMarketableSecurities	-0	usd
CY2024	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	60626000	usd
CY2023	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	26718000	usd
CY2022	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	-326000	usd
CY2024	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	128349000	usd
CY2023	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-285111000	usd
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-21533000	usd
CY2024	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	8619000	usd
CY2023	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	129593000	usd
CY2022	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	262509000	usd
CY2024	tlry	Proceeds From Payment For Warrants And Options Exercised ProceedsFromPaymentForWarrantsAndOptionsExercised	0	usd
CY2023	tlry	Proceeds From Payment For Warrants And Options Exercised ProceedsFromPaymentForWarrantsAndOptionsExercised	0	usd
CY2022	tlry	Proceeds From Payment For Warrants And Options Exercised ProceedsFromPaymentForWarrantsAndOptionsExercised	5403000	usd
CY2024	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	-0	usd
CY2023	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	1189000	usd
CY2022	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	8686000	usd
CY2024	us-gaap	Proceeds From Issuance Of Other Long Term Debt ProceedsFromIssuanceOfOtherLongTermDebt	32621000	usd
CY2023	us-gaap	Proceeds From Issuance Of Other Long Term Debt ProceedsFromIssuanceOfOtherLongTermDebt	1288000	usd
CY2022	us-gaap	Proceeds From Issuance Of Other Long Term Debt ProceedsFromIssuanceOfOtherLongTermDebt	0	usd
CY2024	us-gaap	Repayments Of Other Long Term Debt RepaymentsOfOtherLongTermDebt	22402000	usd
CY2023	us-gaap	Repayments Of Other Long Term Debt RepaymentsOfOtherLongTermDebt	21336000	usd
CY2022	us-gaap	Repayments Of Other Long Term Debt RepaymentsOfOtherLongTermDebt	40254000	usd
CY2024	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	21553000	usd
CY2023	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	145052000	usd
CY2022	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt		usd
CY2024	us-gaap	Repayments Of Convertible Debt RepaymentsOfConvertibleDebt	107330000	usd
CY2023	us-gaap	Repayments Of Convertible Debt RepaymentsOfConvertibleDebt	187394000	usd
CY2022	us-gaap	Repayments Of Convertible Debt RepaymentsOfConvertibleDebt	88026000	usd
CY2024	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	2900000	usd
CY2023	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	1114000	usd
CY2022	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	4672000	usd
CY2024	us-gaap	Proceeds From Repayments Of Short Term Debt ProceedsFromRepaymentsOfShortTermDebt	-5348000	usd
CY2023	us-gaap	Proceeds From Repayments Of Short Term Debt ProceedsFromRepaymentsOfShortTermDebt	5258000	usd
CY2022	us-gaap	Proceeds From Repayments Of Short Term Debt ProceedsFromRepaymentsOfShortTermDebt	9406000	usd
CY2024	us-gaap	Payments Of Dividends Minority Interest PaymentsOfDividendsMinorityInterest	-0	usd
CY2023	us-gaap	Payments Of Dividends Minority Interest PaymentsOfDividendsMinorityInterest	-0	usd
CY2022	us-gaap	Payments Of Dividends Minority Interest PaymentsOfDividendsMinorityInterest	7484000	usd
CY2024	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-75187000	usd
CY2023	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	70158000	usd
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	128196000	usd
CY2024	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-549000	usd
CY2023	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-2230000	usd
CY2022	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-1958000	usd
CY2024	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	21708000	usd
CY2023	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-209277000	usd
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-72557000	usd
CY2023Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	206632000	usd
CY2022Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	415909000	usd
CY2021Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	488466000	usd
CY2024Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	228340000	usd
CY2023Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	206632000	usd
CY2022Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	415909000	usd
CY2024	us-gaap	Basis Of Accounting BasisOfAccounting	<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;"> <tbody> <tr> <td style="vertical-align:top;width:2.8%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b><em style="font: inherit;">2.</em></b></p> </td> <td style="vertical-align:top;width:auto;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Basis of preparation</b></p> </td> </tr> </tbody> </table> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">The policies applied in these consolidated financial statements are prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) and pursuant to the rules and regulations of the United States Securities and Exchange Commission (“SEC”).</p> <p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;"> </p> <p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">These consolidated financial statements have been prepared on the going concern basis which assumes that the Company will continue in operation for the foreseeable future and, accordingly, will be able to realize its assets and discharge its liabilities in the normal course of operations as they come due, under the historical cost convention except for certain financial instruments that are measured at fair value, as detailed in the Company’s accounting policies. </p> <p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"> </p> <p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 18pt; text-align: justify;"><i>Foreign currency</i></p> <p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"> </p> <p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">These consolidated financial statements are presented in U.S. dollars (“USD”), which is the Company’s reporting currency; however, the functional currency of the entities in these financial statements are their respective local currencies, including Canadian dollar, USD, Euro, Australian dollar, and British Pound Sterling.</p> <p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;"> </p> <p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">Foreign currency transactions are remeasured to the respective functional currencies of the Company’s entities at the exchange rates in effect on the date of the transactions. Monetary assets and liabilities denominated in foreign currencies are remeasured to the functional currency at the foreign exchange rate applicable at the statement of financial position date. Non-monetary items carried at historical cost denominated in foreign currencies are remeasured to the functional currency at the date of the transactions. Non-monetary items carried at fair value denominated in foreign currencies are remeasured to the functional currency at the date when the fair value was determined. Realized and unrealized exchange gains and losses are recognized through profit and loss.</p> <p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;"> </p> <p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">On consolidation, the assets and liabilities of foreign operations reported in their functional currencies are translated into USD, the Group’s presentation currency, at period-end exchange rates. Income and expenses, and cash flows of foreign operations are translated into USD using average exchange rates. Exchange differences resulting from translating foreign operations are recognized in other comprehensive income (loss) and accumulated in equity.</p> <p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"> </p> <p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 18pt; text-align: justify;"><i>Basis of consolidation </i></p> <p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"> </p> <p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt -1pt; text-indent: 36pt; text-align: justify;">Subsidiaries are entities controlled by the Company. Control exists when the Company either has a controlling voting interest or is the primary beneficiary of a variable interest entity. The financial statements of all subsidiaries are included in the consolidated financial statements from the date that control commences until the date that control ceases. All intercompany balances and transactions have been eliminated on consolidation. </p> <p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"> </p> <p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 18pt; text-align: justify;"><i>Equity method investments</i></p> <p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"> </p> <p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">In accordance with ASC <em style="font: inherit;">323,</em> <i>Investments </i>–<i> Equity Method and Joint Ventures, </i>investments in entities over which the Company does <em style="font: inherit;">not</em> have a controlling financial interest but has significant influence are accounted for using the equity method, with the Company’s share of earnings or losses reported in earnings or losses from equity method investments on the statements of net loss and comprehensive loss. Equity method investments are recognized initially at cost, which includes transaction costs. After initial recognition, the consolidated financial statements include the Company’s share of undistributed earnings or losses, and impairment, if any, until the date on which significant influence ceases.</p> <p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;"> </p> <p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">If the Company’s share of losses in an equity investment equals or exceeds its interest in the entity, including any net advances, the group does <em style="font: inherit;">not</em> recognize further losses, unless it has guaranteed obligations of the investee or is otherwise committed to provide further financial support for the investee.</p> <p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;"> </p> <p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">Unrealized gains on transactions between the Company and its equity-method investees are eliminated only to the extent of the Company’s interest in these entities. Unrealized losses are also eliminated, except to the extent that the underlying asset is impaired. </p>
CY2024	us-gaap	Use Of Estimates UseOfEstimates	<p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 18pt; text-align: justify;"><i>Critical accounting estimates and judgments</i></p> <p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"> </p> <p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">The preparation of the Company’s financial statements requires management to make judgments, estimates and assumptions that affect the application of policies and reported amounts of assets, liabilities, revenues and expenses. These estimates and judgements are subject to change based on experience and new information which could result in outcomes that require a material adjustment to the carrying amounts of assets or liabilities affecting future periods. Actual results <em style="font: inherit;"> may </em>differ from these estimates. The estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognized prospectively.</p> <p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left"> </p> <p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">Financial statement areas that require significant judgement and estimates are as follows:</p> <p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"> </p> <p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;"><i>Convertible notes receivable </i>–<i> </i>The determination of fair value of the Company’s convertible notes receivable at other than initial cost is subject to certain limitations. Financial information for certain companies in which the Company has investments <em style="font: inherit;"> may </em><em style="font: inherit;">not</em> be available and, even if available, that information <em style="font: inherit;"> may </em>be limited and/or unreliable.</p> <p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"> </p> <p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">Use of the valuation approach described below <em style="font: inherit;"> may </em>involve uncertainties and determinations based on the Company’s judgment and any value estimated from these techniques <em style="font: inherit;"> may </em><em style="font: inherit;">not</em> be realized or realizable.</p> <p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"> </p> <p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">Company-specific information is considered when determining whether the fair value of convertible notes receivable should be adjusted upward or downward at the end of each reporting period. In addition to company-specific information, the Company will consider trends in general market conditions in relation to the convertible notes receivable.</p> <p style="font-family: "Times New Roman", Times, serif; font-size: 10pt; margin: 0pt; text-align: justify;"> </p> <p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">The fair value of convertible notes receivable <em style="font: inherit;"> may </em>need to be adjusted if:</p> <p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"> </p> <table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;"><tbody><tr style="vertical-align: top;"><td style="width: 36pt; text-align: justify;"> </td><td style="width: 18pt;"> <p style="font-family: "Times New Roman", Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">•</p> </td><td style="width: auto;"> <p style="font-family: "Times New Roman", Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">There has been a significant subsequent equity financing provided by outside investors at a valuation different than the current value of the investee company, in which case the fair value of the investment is set to the value at which that financing took place;</p> </td></tr> </tbody></table> <p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"> </p> <table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;"><tbody><tr style="vertical-align: top;"><td style="width: 36pt; text-align: justify;"> </td><td style="width: 18pt;"> <p style="font-family: "Times New Roman", Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">•</p> </td><td style="width: auto;"> <p style="font-family: "Times New Roman", Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">There have been significant corporate, political, or operating events affecting the investee company that, in management’s opinion, have a material impact on the investee company’s prospects and therefore its fair value. In these circumstances, the adjustment to the fair value of the investment will be based on management’s judgment and any value estimated <em style="font: inherit;"> may </em><em style="font: inherit;">not</em> be realized or realizable;</p> </td></tr> </tbody></table> <p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"> </p> <table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;"><tbody><tr style="vertical-align: top;"><td style="width: 36pt; text-align: justify;"> </td><td style="width: 18pt;"> <p style="font-family: "Times New Roman", Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">•</p> </td><td style="width: auto;"> <p style="font-family: "Times New Roman", Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">The investee company is placed into receivership or bankruptcy;</p> </td></tr> </tbody></table> <p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"> </p> <table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;"><tbody><tr style="vertical-align: top;"><td style="width: 36pt; text-align: justify;"> </td><td style="width: 18pt;"> <p style="font-family: "Times New Roman", Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">•</p> </td><td style="width: auto;"> <p style="font-family: "Times New Roman", Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">Based on financial information received from the investee company, it is apparent to the Company that the investee company is unlikely to be able to continue as a going concern;</p> </td></tr> </tbody></table> <p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"> </p> <table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;"><tbody><tr style="vertical-align: top;"><td style="width: 36pt; text-align: justify;"> </td><td style="width: 18pt;"> <p style="font-family: "Times New Roman", Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">•</p> </td><td style="width: auto;"> <p style="font-family: "Times New Roman", Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">Important positive or negative management changes by the investee company that the Company’s management believes will have a positive or negative impact on the investee company’s ability to achieve its objectives and build value for shareholders.</p> </td></tr> </tbody></table> <p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left"> </p> <p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">Adjustment to the fair value of convertible notes receivable will be based upon management’s judgment and any value estimated <em style="font: inherit;"> may </em><em style="font: inherit;">not</em> be realized or realizable. </p> <p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;"> </p> <p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;"><i>Estimated useful lives, impairment considerations and amortization of capital and intangible assets </i>–<i> </i>Amortization of capital and intangible assets is dependent upon estimates of useful lives based on management’s judgment. </p> <p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;"> </p> <p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">Goodwill and indefinite-lived intangible asset impairment testing require management to make estimates in the impairment testing model. On at least an annual basis, the Company tests whether goodwill and indefinite-lived intangible assets are impaired. Impairment of definite long-lived assets is influenced by judgment in defining a reporting unit and determining the indicators of impairment, and estimates used to measure impairment losses.</p> <p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;"> </p> <p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">The reporting unit’s fair value is determined using discounted future cash flow models, which incorporate assumptions regarding future events, specifically future cash flows, growth rates and discount rates.</p> <p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"> </p> <p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;"><i>Business combinations </i>–<i> </i>Judgement is used in determining a) whether an acquisition is a business combination or an asset acquisition. We use judgement in applying the acquisition method of accounting for business combinations and estimates to value identifiable assets and liabilities at the acquisition date. Estimates are used to determine cash flow projections, including the period of future benefit, and future growth and discount rates, among other factors. The values allocated to the acquired assets and liabilities assumed affect the amount of goodwill recorded on acquisition. Fair value of assets acquired and liabilities assumed is typically estimated using an income approach, which is based on the present value of future discounted cash flows. Significant estimates in the discounted cash flow model include the discount rate, rate of future revenue growth and profitability of the acquired business and working capital effects. The discount rate considers the relevant risk associated with the business-specific characteristics and the uncertainty related to the ability to achieve projected cash flows. These estimates and the resulting valuations require significant judgment. Management engages <em style="font: inherit;">third</em> party experts to assist in the valuation of material acquisitions.</p> <p style="font-family: "Times New Roman", Times, serif; font-size: 10pt; margin: 0pt; text-align: justify;"> </p> <p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;"><i>Convertible debentures </i>–<i> </i>The fair value of Convertible Debentures where the Company had elected the fair value option are determined using the Black-Scholes option pricing model. Assumptions and estimates are made in determining an appropriate conversion price, volatility, dividend yield, and the fair value of common stock. There is judgement in assessing what portion of the gain or loss, if any, relates to the change in the instrument-specific credit risk.</p> <p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"> </p> <p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 18pt; text-indent: 18pt; text-align: justify;"></p>
CY2024Q2	us-gaap	Inventory Net InventoryNet	252087000	usd
CY2023Q2	us-gaap	Inventory Net InventoryNet	200551000	usd
CY2024Q2	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset Before Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization	747822000	usd
CY2023Q2	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset Before Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization	576485000	usd
CY2024Q2	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization	189575000	usd
CY2023Q2	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization	146818000	usd
CY2024Q2	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization	558247000	usd
CY2023Q2	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization	429667000	usd
CY2024Q2	us-gaap	Assets Held For Sale Not Part Of Disposal Group AssetsHeldForSaleNotPartOfDisposalGroup	32074000	usd
CY2023Q2	us-gaap	Assets Held For Sale Not Part Of Disposal Group AssetsHeldForSaleNotPartOfDisposalGroup	0	usd
CY2024Q2	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	43993000	usd
CY2023Q2	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	0	usd
CY2024Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	16101000	usd
CY2023Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	5941000	usd
CY2024Q2	tlry	Operating And Finance Leases Rightofuse Assets Total OperatingAndFinanceLeasesRightofuseAssetsTotal	60094000	usd
CY2023Q2	tlry	Operating And Finance Leases Rightofuse Assets Total OperatingAndFinanceLeasesRightofuseAssetsTotal	5941000	usd
CY2024Q2	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	1092000	usd
CY2023Q2	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	0	usd
CY2024Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	3999000	usd
CY2023Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	2423000	usd
CY2024Q2	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	43948000	usd
CY2023Q2	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	0	usd
CY2024Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	16474000	usd
CY2023Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	7936000	usd
CY2024Q2	tlry	Operating And Financing Lease Liability OperatingAndFinancingLeaseLiability	65513000	usd
CY2023Q2	tlry	Operating And Financing Lease Liability OperatingAndFinancingLeaseLiability	10359000	usd
CY2024	us-gaap	Lease Cost LeaseCost	4582000	usd
CY2024	us-gaap	Sublease Income SubleaseIncome	738000	usd
CY2023	us-gaap	Lease Cost LeaseCost	3140000	usd
CY2023	us-gaap	Sublease Income SubleaseIncome	662000	usd
CY2024Q2	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	5821000	usd
CY2024Q2	us-gaap	Finance Lease Liability Payments Due Next Twelve Months FinanceLeaseLiabilityPaymentsDueNextTwelveMonths	4036000	usd
CY2024Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	5540000	usd
CY2024Q2	us-gaap	Finance Lease Liability Payments Due Year Two FinanceLeaseLiabilityPaymentsDueYearTwo	4036000	usd
CY2024Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	4893000	usd
CY2024Q2	us-gaap	Finance Lease Liability Payments Due Year Three FinanceLeaseLiabilityPaymentsDueYearThree	4036000	usd
CY2024Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	3997000	usd
CY2024Q2	us-gaap	Finance Lease Liability Payments Due Year Four FinanceLeaseLiabilityPaymentsDueYearFour	4036000	usd
CY2024Q2	tlry	Lessee Operating Lease Liability To Be Paid After Year Three LesseeOperatingLeaseLiabilityToBePaidAfterYearThree	6101000	usd
CY2024Q2	tlry	Finance Lease Liability To Be Paid After Year Three FinanceLeaseLiabilityToBePaidAfterYearThree	79993000	usd
CY2024Q2	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	26352000	usd
CY2024Q2	us-gaap	Finance Lease Liability Payments Due FinanceLeaseLiabilityPaymentsDue	96137000	usd
CY2024Q2	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	5879000	usd
CY2024Q2	us-gaap	Finance Lease Liability Undiscounted Excess Amount FinanceLeaseLiabilityUndiscountedExcessAmount	51097000	usd
CY2024Q2	us-gaap	Operating Lease Liability OperatingLeaseLiability	20473000	usd
CY2024Q2	us-gaap	Finance Lease Liability FinanceLeaseLiability	45040000	usd
CY2024Q2	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	1593071000	usd
CY2023Q2	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	1576717000	usd
CY2024Q2	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	261758000	usd
CY2023Q2	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	187088000	usd
CY2024Q2	tlry	Intangible Assets Net Excluding Goodwill Accumulated Impairment IntangibleAssetsNetExcludingGoodwillAccumulatedImpairment	415844000	usd
CY2023Q2	tlry	Intangible Assets Net Excluding Goodwill Accumulated Impairment IntangibleAssetsNetExcludingGoodwillAccumulatedImpairment	415844000	usd
CY2024Q2	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	915469000	usd
CY2023Q2	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	973785000	usd
CY2024	us-gaap	Impairment Of Intangible Assets Excluding Goodwill ImpairmentOfIntangibleAssetsExcludingGoodwill	0	usd
CY2024Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	75988000	usd
CY2024Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	75988000	usd
CY2024Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	75988000	usd
CY2024Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	75988000	usd
CY2024Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	75988000	usd
CY2024Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense After Year Five FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive	352678000	usd
CY2024Q2	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	732618000	usd
CY2023Q3	tlry	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Noncurrent Assets Finance Lease Right Of Use Assets BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssetsFinanceLeaseRightOfUseAssets	45496000	usd
CY2024Q2	tlry	Goodwill Accumulated Foreign Currency Translation Gain Loss GoodwillAccumulatedForeignCurrencyTranslationGainLoss	-7916000	usd
CY2023Q2	tlry	Goodwill Accumulated Foreign Currency Translation Gain Loss GoodwillAccumulatedForeignCurrencyTranslationGainLoss	-7875000	usd
CY2024Q2	us-gaap	Goodwill Impaired Accumulated Impairment Loss GoodwillImpairedAccumulatedImpairmentLoss	842431000	usd
CY2023Q2	us-gaap	Goodwill Impaired Accumulated Impairment Loss GoodwillImpairedAccumulatedImpairmentLoss	842431000	usd
CY2024Q2	us-gaap	Goodwill Goodwill	2008884000	usd
CY2023Q2	us-gaap	Goodwill Goodwill	2008843000	usd
CY2024Q2	us-gaap	Notes Receivable Net NotesReceivableNet	32000000	usd
CY2023Q2	us-gaap	Notes Receivable Net NotesReceivableNet	103401000	usd
CY2024Q2	us-gaap	Notes And Loans Receivable Net Current NotesAndLoansReceivableNetCurrent	0	usd
CY2023Q2	us-gaap	Notes And Loans Receivable Net Current NotesAndLoansReceivableNetCurrent	0	usd
CY2024Q2	us-gaap	Notes And Loans Receivable Net Noncurrent NotesAndLoansReceivableNetNoncurrent	32000000	usd
CY2023Q2	us-gaap	Notes And Loans Receivable Net Noncurrent NotesAndLoansReceivableNetNoncurrent	103401000	usd
CY2024Q2	us-gaap	Equity Method Investments Fair Value Disclosure EquityMethodInvestmentsFairValueDisclosure	2359000	usd
CY2023Q2	us-gaap	Equity Method Investments Fair Value Disclosure EquityMethodInvestmentsFairValueDisclosure	2144000	usd
CY2024Q2	us-gaap	Equity Securities Without Readily Determinable Fair Value Amount EquitySecuritiesWithoutReadilyDeterminableFairValueAmount	5500000	usd
CY2023Q2	us-gaap	Equity Securities Without Readily Determinable Fair Value Amount EquitySecuritiesWithoutReadilyDeterminableFairValueAmount	5651000	usd
CY2024Q2	us-gaap	Long Term Investments LongTermInvestments	7859000	usd
CY2023Q2	us-gaap	Long Term Investments LongTermInvestments	7795000	usd
CY2024	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	217000	usd
CY2023	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	2366000	usd
CY2022	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	6731000	usd
CY2024	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	-126735000	usd
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	-506984000	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	-233697000	usd
CY2024	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-249020000	usd
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-1450181000	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-440674000	usd
CY2024	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	497000	usd
CY2023	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	226000	usd
CY2022	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	262000	usd
CY2024	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	12256000	usd
CY2023	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	26454000	usd
CY2022	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	24009000	usd
CY2024	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-723000	usd
CY2023	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-4055000	usd
CY2022	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	520000	usd
CY2024	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-38872000	usd
CY2023	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-33635000	usd
CY2022	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-30551000	usd
CY2024	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-26616000	usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-7181000	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-6542000	usd
CY2024	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-249020000	usd
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-1450181000	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-440674000	usd
CY2024	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-51325000	usd
CY2023	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-304538000	usd
CY2022	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-92542000	usd
CY2024	us-gaap	Income Tax Reconciliation Foreign Income Tax Rate Differential IncomeTaxReconciliationForeignIncomeTaxRateDifferential	-5661000	usd
CY2023	us-gaap	Income Tax Reconciliation Foreign Income Tax Rate Differential IncomeTaxReconciliationForeignIncomeTaxRateDifferential	-25857000	usd
CY2022	us-gaap	Income Tax Reconciliation Foreign Income Tax Rate Differential IncomeTaxReconciliationForeignIncomeTaxRateDifferential	81316000	usd
CY2024	us-gaap	Income Tax Reconciliation Tax Contingencies Foreign IncomeTaxReconciliationTaxContingenciesForeign	1959000	usd
CY2023	us-gaap	Income Tax Reconciliation Tax Contingencies Foreign IncomeTaxReconciliationTaxContingenciesForeign	13434000	usd
CY2022	us-gaap	Income Tax Reconciliation Tax Contingencies Foreign IncomeTaxReconciliationTaxContingenciesForeign	14941000	usd
CY2024	us-gaap	Income Tax Reconciliation Nondeductible Expense IncomeTaxReconciliationNondeductibleExpense	6147000	usd
CY2023	us-gaap	Income Tax Reconciliation Nondeductible Expense IncomeTaxReconciliationNondeductibleExpense	3982000	usd
CY2022	us-gaap	Income Tax Reconciliation Nondeductible Expense IncomeTaxReconciliationNondeductibleExpense	6404000	usd
CY2024	tlry	Effective Income Tax Rate Reconciliation Nondeductible Taxable Losses EffectiveIncomeTaxRateReconciliationNondeductibleTaxableLosses	-682000	usd
CY2023	tlry	Effective Income Tax Rate Reconciliation Nondeductible Taxable Losses EffectiveIncomeTaxRateReconciliationNondeductibleTaxableLosses	23150000	usd
CY2022	tlry	Effective Income Tax Rate Reconciliation Nondeductible Taxable Losses EffectiveIncomeTaxRateReconciliationNondeductibleTaxableLosses	748000	usd
CY2024	us-gaap	Income Tax Reconciliation Change In Enacted Tax Rate IncomeTaxReconciliationChangeInEnactedTaxRate	2394000	usd
CY2023	us-gaap	Income Tax Reconciliation Change In Enacted Tax Rate IncomeTaxReconciliationChangeInEnactedTaxRate	-816000	usd
CY2022	us-gaap	Income Tax Reconciliation Change In Enacted Tax Rate IncomeTaxReconciliationChangeInEnactedTaxRate	0	usd
CY2024	tlry	Effective Income Tax Rate Reconciliation Change In Fair Value Of Warrant Liability EffectiveIncomeTaxRateReconciliationChangeInFairValueOfWarrantLiability	302000	usd
CY2023	tlry	Effective Income Tax Rate Reconciliation Change In Fair Value Of Warrant Liability EffectiveIncomeTaxRateReconciliationChangeInFairValueOfWarrantLiability	-2612000	usd
CY2022	tlry	Effective Income Tax Rate Reconciliation Change In Fair Value Of Warrant Liability EffectiveIncomeTaxRateReconciliationChangeInFairValueOfWarrantLiability	-13359000	usd
CY2024	tlry	Effective Income Tax Rate Reconciliation Stock Based And Other Compensation EffectiveIncomeTaxRateReconciliationStockBasedAndOtherCompensation	0	usd
CY2023	tlry	Effective Income Tax Rate Reconciliation Stock Based And Other Compensation EffectiveIncomeTaxRateReconciliationStockBasedAndOtherCompensation	0	usd
CY2022	tlry	Effective Income Tax Rate Reconciliation Stock Based And Other Compensation EffectiveIncomeTaxRateReconciliationStockBasedAndOtherCompensation	994000	usd
CY2024	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	20250000	usd
CY2023	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	285698000	usd
CY2022	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	17255000	usd
CY2024	tlry	Effective Income Tax Rate Reconciliation Impact On Convertible Debenture And Other Differences EffectiveIncomeTaxRateReconciliationImpactOnConvertibleDebentureAndOtherDifferences	-0	usd
CY2023	tlry	Effective Income Tax Rate Reconciliation Impact On Convertible Debenture And Other Differences EffectiveIncomeTaxRateReconciliationImpactOnConvertibleDebentureAndOtherDifferences	-378000	usd
CY2022	tlry	Effective Income Tax Rate Reconciliation Impact On Convertible Debenture And Other Differences EffectiveIncomeTaxRateReconciliationImpactOnConvertibleDebentureAndOtherDifferences	22299000	usd
CY2024	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-26616000	usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-7181000	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-6542000	usd
CY2024Q2	us-gaap	Deferred Tax Assets Operating Loss Carryforwards Domestic DeferredTaxAssetsOperatingLossCarryforwardsDomestic	104377000	usd
CY2023Q2	us-gaap	Deferred Tax Assets Operating Loss Carryforwards Domestic DeferredTaxAssetsOperatingLossCarryforwardsDomestic	85259000	usd
CY2024Q2	us-gaap	Deferred Tax Assets Capital Loss Carryforwards DeferredTaxAssetsCapitalLossCarryforwards	34355000	usd
CY2023Q2	us-gaap	Deferred Tax Assets Capital Loss Carryforwards DeferredTaxAssetsCapitalLossCarryforwards	34355000	usd
CY2024Q2	us-gaap	Deferred Tax Assets Goodwill And Intangible Assets DeferredTaxAssetsGoodwillAndIntangibleAssets	229953000	usd
CY2023Q2	us-gaap	Deferred Tax Assets Goodwill And Intangible Assets DeferredTaxAssetsGoodwillAndIntangibleAssets	244227000	usd
CY2024Q2	us-gaap	Deferred Tax Assets Property Plant And Equipment DeferredTaxAssetsPropertyPlantAndEquipment	34578000	usd
CY2023Q2	us-gaap	Deferred Tax Assets Property Plant And Equipment DeferredTaxAssetsPropertyPlantAndEquipment	46400000	usd
CY2024Q2	us-gaap	Deferred Tax Asset Interest Carryforward DeferredTaxAssetInterestCarryforward	0	usd
CY2023Q2	us-gaap	Deferred Tax Asset Interest Carryforward DeferredTaxAssetInterestCarryforward	2812000	usd
CY2024Q2	us-gaap	Deferred Tax Assets Investments DeferredTaxAssetsInvestments	45685000	usd
CY2023Q2	us-gaap	Deferred Tax Assets Investments DeferredTaxAssetsInvestments	66718000	usd
CY2024Q2	us-gaap	Deferred Tax Assets Tax Credit Carryforwards DeferredTaxAssetsTaxCreditCarryforwards	23132000	usd
CY2023Q2	us-gaap	Deferred Tax Assets Tax Credit Carryforwards DeferredTaxAssetsTaxCreditCarryforwards	22054000	usd
CY2024Q2	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	46151000	usd
CY2023Q2	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	50074000	usd
CY2024Q2	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	903469000	usd
CY2023Q2	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	715797000	usd
CY2024Q2	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	789839000	usd
CY2023Q2	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	625368000	usd
CY2024Q2	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	113630000	usd
CY2023Q2	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	90429000	usd
CY2024Q2	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	18814000	usd
CY2023Q2	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	18129000	usd
CY2024Q2	us-gaap	Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets	218020000	usd
CY2023Q2	us-gaap	Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets	225460000	usd
CY2024Q2	us-gaap	Deferred Tax Liabilities Financing Arrangements DeferredTaxLiabilitiesFinancingArrangements	2229000	usd
CY2023Q2	us-gaap	Deferred Tax Liabilities Financing Arrangements DeferredTaxLiabilitiesFinancingArrangements	14204000	usd
CY2024Q2	us-gaap	Deferred Tax Liabilities Other DeferredTaxLiabilitiesOther	5437000	usd
CY2023Q2	us-gaap	Deferred Tax Liabilities Other DeferredTaxLiabilitiesOther	-0	usd
CY2024Q2	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	244500000	usd
CY2023Q2	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	257793000	usd
CY2024Q2	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	130870000	usd
CY2023Q2	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	167364000	usd
CY2017Q4	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.35	pure
CY2024	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21	pure
CY2024Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	105392000	usd
CY2023Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	70819000	usd
CY2024Q2	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	92424000	usd
CY2023Q2	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	48394000	usd
CY2024Q2	tlry	Accrued Litigation Expense AccruedLitigationExpense	24378000	usd
CY2023Q2	tlry	Accrued Litigation Expense AccruedLitigationExpense	25000000	usd
CY2024Q2	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	6154000	usd
CY2023Q2	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	18772000	usd
CY2024Q2	us-gaap	Taxes Payable Current TaxesPayableCurrent	4092000	usd
CY2023Q2	us-gaap	Taxes Payable Current TaxesPayableCurrent	14934000	usd
CY2024Q2	us-gaap	Interest Payable Current InterestPayableCurrent	4217000	usd
CY2023Q2	us-gaap	Interest Payable Current InterestPayableCurrent	8102000	usd
CY2024Q2	us-gaap	Sales And Excise Tax Payable Current And Noncurrent SalesAndExciseTaxPayableCurrentAndNoncurrent	5300000	usd
CY2023Q2	us-gaap	Sales And Excise Tax Payable Current And Noncurrent SalesAndExciseTaxPayableCurrentAndNoncurrent	4661000	usd
CY2024Q2	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	241957000	usd
CY2023Q2	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	190682000	usd
CY2024Q2	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	129913000	usd
CY2023Q2	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	395422000	usd
CY2024Q2	us-gaap	Convertible Debt Current ConvertibleDebtCurrent	330000	usd
CY2023Q2	us-gaap	Convertible Debt Current ConvertibleDebtCurrent	174378000	usd
CY2024Q2	us-gaap	Convertible Debt Noncurrent ConvertibleDebtNoncurrent	129583000	usd
CY2023Q2	us-gaap	Convertible Debt Noncurrent ConvertibleDebtNoncurrent	221044000	usd
CY2024Q2	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	5.95
CY2024Q2	tlry	Percentage Of Daily Cash Penalty PercentageOfDailyCashPenalty	0.01	pure
CY2024Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	1198000000
CY2024Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000
CY2024Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	831925373
CY2023Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	980000000
CY2023Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000
CY2023Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	656655455
CY2024	us-gaap	Stock Issued During Period Shares Share Based Compensation StockIssuedDuringPeriodSharesShareBasedCompensation	4351237
CY2024	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	31769000	usd
CY2023	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	39595000	usd
CY2022	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	35994000	usd
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	371182
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	11.37
CY2024	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod	0
CY2024	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	0
CY2024	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod	123113
CY2024	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue	6.47
CY2024	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod	3876
CY2024	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue	6.9
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	244193
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	13.91
CY2024	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	788942000	usd
CY2023	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	627124000	usd
CY2022	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	628372000	usd
CY2024	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	565591000	usd
CY2023	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	480164000	usd
CY2022	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	511555000	usd
CY2024	us-gaap	Compensation Expense Excluding Cost Of Good And Service Sold CompensationExpenseExcludingCostOfGoodAndServiceSold	15597000	usd
CY2023	us-gaap	Compensation Expense Excluding Cost Of Good And Service Sold CompensationExpenseExcludingCostOfGoodAndServiceSold	13655000	usd
CY2022	us-gaap	Compensation Expense Excluding Cost Of Good And Service Sold CompensationExpenseExcludingCostOfGoodAndServiceSold	14128000	usd
CY2024	tlry	Office And General Expense OfficeAndGeneralExpense	28460000	usd
CY2023	tlry	Office And General Expense OfficeAndGeneralExpense	27845000	usd
CY2022	tlry	Office And General Expense OfficeAndGeneralExpense	27153000	usd
CY2024	us-gaap	Salaries Wages And Officers Compensation SalariesWagesAndOfficersCompensation	68076000	usd
CY2023	us-gaap	Salaries Wages And Officers Compensation SalariesWagesAndOfficersCompensation	57228000	usd
CY2022	us-gaap	Salaries Wages And Officers Compensation SalariesWagesAndOfficersCompensation	51693000	usd
CY2024	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	31769000	usd
CY2023	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	39595000	usd
CY2022	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	35994000	usd
CY2024	us-gaap	General Insurance Expense GeneralInsuranceExpense	12586000	usd
CY2023	us-gaap	General Insurance Expense GeneralInsuranceExpense	12033000	usd
CY2022	us-gaap	General Insurance Expense GeneralInsuranceExpense	17536000	usd
CY2024	us-gaap	Professional Fees ProfessionalFees	5345000	usd
CY2023	us-gaap	Professional Fees ProfessionalFees	7166000	usd
CY2022	us-gaap	Professional Fees ProfessionalFees	13047000	usd
CY2024	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	4198000	usd
CY2023	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	48000	usd
CY2022	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	682000	usd
CY2024	us-gaap	Proceeds From Insurance Premiums Collected ProceedsFromInsurancePremiumsCollected	-0	usd
CY2023	us-gaap	Proceeds From Insurance Premiums Collected ProceedsFromInsurancePremiumsCollected	-0	usd
CY2022	us-gaap	Proceeds From Insurance Premiums Collected ProceedsFromInsurancePremiumsCollected	4032000	usd
CY2024	us-gaap	Travel And Entertainment Expense TravelAndEntertainmentExpense	5138000	usd
CY2023	us-gaap	Travel And Entertainment Expense TravelAndEntertainmentExpense	4530000	usd
CY2022	us-gaap	Travel And Entertainment Expense TravelAndEntertainmentExpense	4203000	usd
CY2024	us-gaap	Operating Lease Expense OperatingLeaseExpense	4585000	usd
CY2023	us-gaap	Operating Lease Expense OperatingLeaseExpense	3155000	usd
CY2022	us-gaap	Operating Lease Expense OperatingLeaseExpense	3761000	usd
CY2024	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	167358000	usd
CY2023	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	165159000	usd
CY2022	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	162801000	usd
CY2024	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	4198000	usd
CY2024	us-gaap	Restructuring Costs RestructuringCosts	15581000	usd
CY2023	us-gaap	Restructuring Costs RestructuringCosts	9245000	usd
CY2022	us-gaap	Restructuring Costs RestructuringCosts	795000	usd
CY2023	us-gaap	Restructuring Costs RestructuringCosts	9245000	usd
CY2024	us-gaap	Investment Income Interest InvestmentIncomeInterest	12831000	usd
CY2023	us-gaap	Investment Income Interest InvestmentIncomeInterest	33025000	usd
CY2022	us-gaap	Investment Income Interest InvestmentIncomeInterest	11736000	usd
CY2024	us-gaap	Interest Expense InterestExpense	49264000	usd
CY2023	us-gaap	Interest Expense InterestExpense	46612000	usd
CY2022	us-gaap	Interest Expense InterestExpense	39680000	usd
CY2024	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	-36433000	usd
CY2023	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	-13587000	usd
CY2022	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	-27944000	usd
CY2024	us-gaap	Debt Securities Available For Sale Realized Gain Loss DebtSecuritiesAvailableForSaleRealizedGainLoss	-19736000	usd
CY2023	us-gaap	Debt Securities Available For Sale Realized Gain Loss DebtSecuritiesAvailableForSaleRealizedGainLoss	-43651000	usd
CY2022	us-gaap	Debt Securities Available For Sale Realized Gain Loss DebtSecuritiesAvailableForSaleRealizedGainLoss	163670000	usd
CY2024	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	1436000	usd
CY2023	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-12438000	usd
CY2022	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-63913000	usd
CY2024	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-4086000	usd
CY2023	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-25535000	usd
CY2022	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-28383000	usd
CY2024	tlry	Gain Loss On Long Term Investments GainLossOnLongTermInvestments	-217000	usd
CY2023	tlry	Gain Loss On Long Term Investments GainLossOnLongTermInvestments	-2190000	usd
CY2022	tlry	Gain Loss On Long Term Investments GainLossOnLongTermInvestments	-6737000	usd
CY2024	us-gaap	Other Nonoperating Gains Losses OtherNonoperatingGainsLosses	-12367000	usd
CY2023	us-gaap	Other Nonoperating Gains Losses OtherNonoperatingGainsLosses	-7971000	usd
CY2022	us-gaap	Other Nonoperating Gains Losses OtherNonoperatingGainsLosses	5208000	usd
CY2024	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-37842000	usd
CY2023	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-66909000	usd
CY2022	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	197671000	usd
CY2024	us-gaap	Other Nonoperating Gains Losses OtherNonoperatingGainsLosses	-12367000	usd
CY2024	tlry	Noncontrolling Interest Amounts To Settle Outstanding Notes NoncontrollingInterestAmountsToSettleOutstandingNotes	2458000	usd
CY2024Q2	us-gaap	Contractual Obligation ContractualObligation	408030000	usd
CY2024Q2	us-gaap	Contractual Obligation Due In Next Twelve Months ContractualObligationDueInNextTwelveMonths	42822000	usd
CY2024Q2	us-gaap	Contractual Obligation Due In Second Year ContractualObligationDueInSecondYear	76781000	usd
CY2024Q2	us-gaap	Contractual Obligation Due In Third Year ContractualObligationDueInThirdYear	184264000	usd
CY2024Q2	us-gaap	Contractual Obligation Due In Fourth Year ContractualObligationDueInFourthYear	68672000	usd
CY2024Q2	tlry	Contractual Obligation To Be Paid After Year Four ContractualObligationToBePaidAfterYearFour	35491000	usd
CY2024Q2	us-gaap	Loss Contingency Accrual At Carrying Value LossContingencyAccrualAtCarryingValue	24378000	usd
CY2023Q2	us-gaap	Loss Contingency Accrual At Carrying Value LossContingencyAccrualAtCarryingValue	25000000	usd
CY2024Q2	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	7714000	usd
CY2023Q2	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	6641000	usd
CY2024Q2	us-gaap	Accounts Receivable Gross Noncurrent AccountsReceivableGrossNoncurrent	101695000	usd
CY2024Q2	tlry	Accounts Receivable Gross Noncurrent Percentage Of Total Aging Receivables AccountsReceivableGrossNoncurrentPercentageOfTotalAgingReceivables		pure
CY2022Q2	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	5404000	usd
CY2023	us-gaap	Allowance For Doubtful Accounts Receivable Period Increase Decrease AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease	1237000	usd
CY2023Q2	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	6641000	usd
CY2021Q2	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	4571000	usd
CY2022	us-gaap	Allowance For Doubtful Accounts Receivable Period Increase Decrease AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease	833000	usd
CY2022Q2	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	5404000	usd
CY2024	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	788942000	usd
CY2023	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	627124000	usd
CY2022	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	628372000	usd
CY2024Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	558247000	usd
CY2023Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	429667000	usd
CY2024	dei	Auditor Name AuditorName	PricewaterhouseCoopers LLP
CY2024	dei	Auditor Location AuditorLocation	Toronto, Canada
CY2024	dei	Auditor Firm AuditorFirmId	2024

Files In Submission

Name	View Source	Status
0001437749-24-023774-index-headers.html	Edgar Link	pending
0001437749-24-023774-index.html	Edgar Link	pending
0001437749-24-023774.txt	Edgar Link	pending
0001437749-24-023774-xbrl.zip	Edgar Link	pending
ex_657923.htm	Edgar Link	pending
ex_657924.htm	Edgar Link	pending
ex_657925.htm	Edgar Link	pending
ex_657926.htm	Edgar Link	pending
ex_657927.htm	Edgar Link	pending
ex_657928.htm	Edgar Link	pending
ex_700089.htm	Edgar Link	pending
ex_700090.htm	Edgar Link	pending
ex_700091.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R100.htm	Edgar Link	pending
R101.htm	Edgar Link	pending
R102.htm	Edgar Link	pending
R103.htm	Edgar Link	pending
R104.htm	Edgar Link	pending
R105.htm	Edgar Link	pending
R106.htm	Edgar Link	pending
R107.htm	Edgar Link	pending
R108.htm	Edgar Link	pending
R109.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R110.htm	Edgar Link	pending
R111.htm	Edgar Link	pending
R112.htm	Edgar Link	pending
R113.htm	Edgar Link	pending
R114.htm	Edgar Link	pending
R115.htm	Edgar Link	pending
R116.htm	Edgar Link	pending
R117.htm	Edgar Link	pending
R118.htm	Edgar Link	pending
R119.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R120.htm	Edgar Link	pending
R121.htm	Edgar Link	pending
R122.htm	Edgar Link	pending
R123.htm	Edgar Link	pending
R124.htm	Edgar Link	pending
R125.htm	Edgar Link	pending
R126.htm	Edgar Link	pending
R127.htm	Edgar Link	pending
R128.htm	Edgar Link	pending
R129.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R130.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R81.htm	Edgar Link	pending
R82.htm	Edgar Link	pending
R83.htm	Edgar Link	pending
R84.htm	Edgar Link	pending
R85.htm	Edgar Link	pending
R86.htm	Edgar Link	pending
R87.htm	Edgar Link	pending
R88.htm	Edgar Link	pending
R89.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
R90.htm	Edgar Link	pending
R91.htm	Edgar Link	pending
R92.htm	Edgar Link	pending
R93.htm	Edgar Link	pending
R94.htm	Edgar Link	pending
R95.htm	Edgar Link	pending
R96.htm	Edgar Link	pending
R97.htm	Edgar Link	pending
R98.htm	Edgar Link	pending
R99.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
stockperformanceg.jpg	Edgar Link	pending
tlry-20240531.xsd	Edgar Link	pending
tlry20240531c_10k.htm	Edgar Link	pending
tlry-20240531_cal.xml	Edgar Link	unprocessable
tlry-20240531_def.xml	Edgar Link	unprocessable
tlry-20240531_lab.xml	Edgar Link	unprocessable
tlry-20240531_pre.xml	Edgar Link	unprocessable
tlry20240531c_10k_htm.xml	Edgar Link	completed
FilingSummary.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$TLRY
Tilray Brands, Inc. Stock $tlry

2024 Q3 Form 10-K Financial Statement

#000143774924023774 Filed on July 30, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$TLRY Tilray Brands, Inc. Stock $tlry

2024 Q3 Form 10-K Financial Statement

#000143774924023774 Filed on July 30, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$TLRY
Tilray Brands, Inc. Stock $tlry